SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
FORM 6-K
|
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2025
Commission File Number: 001-38283
|
InflaRx N.V.
(Translation of registrant's name into English) |
|
Winzerlaer Str. 2
07745 Jena, Germany (Address of principal executive office) |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Exhibits 99.1 and 99.2 to this report on Form 6-K (the “Report”) shall be deemed to be incorporated by reference into (i) the registration statements on Form S-8 (File No. 333-221656 and 333-240185) and (ii) the registration statement on Form F-3 (File No. 333-273058) of
InflaRx N.V. and to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
|
Exhibit No.
|
Description
|
|
InflaRx N.V. Unaudited Condensed Consolidated Financial Statements as of and for the Nine Months Ended September 30, 2025
|
|
|
InflaRx N.V. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
INFLARX N.V.
|
|||
|
Date: November 10, 2025
|
By:
|
/s/ Niels Riedemann
|
|
|
Name:
|
Niels Riedemann
|
||
|
Title:
|
Chief Executive Officer
|
||